Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa

Mucosal Immunology

Volumn 9, Issue 6, 2016, Pages 1429-1441

  Mulcahy, M E ^a   Leech, J M ^a   Renauld, J C ^b   Mills, K H G ^a   McLoughlin, R M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 10; INTERLEUKIN 17; INTERLEUKIN 22; LORICRIN; ADENOSINE PHOSPHATE; ANTIMICROBIAL CATIONIC PEPTIDE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; IL 22 GENE; IMMUNE RESPONSE; KERATINOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; STAPHYLOCOCCUS AUREUS; TISSUE DISTRIBUTION; UPREGULATION; WILD TYPE; ANIMAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE SUBPOPULATION;

ADENOSINE MONOPHOSPHATE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INTERLEUKINS; KERATINOCYTES; MICE; MICE, KNOCKOUT; NASAL MUCOSA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTE SUBSETS;

EID: 84991717219     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.24     Document Type: Article

References (50)

1. Van Belkum, A., et al. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199, 1820-1826 (2009
2. Mermel, L.A., Cartony, J.M., Covington, P., Maxey, G., & Morse, D. Methicillin-resistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis. J. Clin. Microbiol. 49, 1119-1121 (2011
3. Wertheim, H.F., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364, 703-705 (2004
4. Cookson, B.D. Mupirocin resistance in staphylococci. J. Antimicrob. Chemother. 25, 497-501 (1990
5. Baur, S., et al. A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization. PLoS Pathog. 10, e1004089 (2014
6. Mulcahy,M.E., et al. Nasal colonisation byStaphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog. 8, e1003092 (2012
7. Cole, A.M., et al. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 8, 1064-1069 (2001
8. Nakamura, M.M., McAdam, A.J., Sandora, T.J.,Moreira, K.R., & Lee, G.M. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J. Clin. Microbiol. 48, 2957-2959 (2010
9. Emonts, M., et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197, 1244-1253 (2008
10. Nurjadi, D., Herrmann, E., Hinderberger, I., & Zanger, P. Impaired betadefensin expression in human skin links DEFB1 promoter polymorphisms with persistent Staphylococcus aureus nasal carriage. J. Infect. Dis. 207, 666-674 (2013
11. Van Belkum, A., et al. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect. 9, 1471-1477 (2007
12. Zanger, P., Nurjadi, D., Vath, B., & Kremsner, P.G. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Infect. Immun. 79, 2658-2662 (2011
13. Verkaik, N.J., et al. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin. Microbiol. Infect. 16, 1312-1317 (2010
14. Padoveze, M.C., De Jesus Pedro, R., Blum-Menezes, D., Bratfich, O.J., & Moretti, M.L. Staphylococcus aureus nasal colonization in HIV outpatients: persistent or transient? Am. J. Infect. Control 36, 187-191 (2008
15. Archer, N.K., Harro, J.M., & Shirtliff, M.E. Clearance of Staphylococcus aureus nasal carriage is Tcell dependent andmediated through interleukin-expression and neutrophil influx. Infect. Immun. 81, 2070-2075 (2013
16. Zheng, Y., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008
17. Sonnenberg, G.F., Fouser, L.A., & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383-390 (2011
18. Liang, S.C., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006
19. Aujla, S.J., et al. IL-22 mediates mucosal host defense against Gramnegative bacterial pneumonia. Nat. Med. 14, 275-281 (2008
20. Wolk, K., et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004
21. Boniface, K., et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695-3702 (2005
22. Wolk, K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006
23. Ahlfors, H., et al. IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. 193, 4602-4613 (2014
24. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857-863 (2009
25. Nomura, T., Kabashima, K., &Miyachi, Y. The panoply of alphabetaTcells in the skin. J. Dermatol. Sci. 76, 3-9 (2014
26. Cella, M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009
27. Satoh-Takayama, N., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008
28. Van Maele, L., et al. Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J. Infect. Dis. 210, 493-503 (2014
29. Simonian, P.L., et al. gammadelta T cells protect against lung fibrosis via IL-22. J. Exp. Med. 207, 2239-2253 (2010
30. Mielke, L.A., et al. Retinoic acid expression associates with enhanced IL-22 production by gammadelta Tcells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210, 1117-1124 (2013
31. De Repentigny, L., Goupil, M., & Jolicoeur, P. Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 Transgene. Pathogens 4, 406-421 (2015
32. Gauguet, S., et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 83, 4003-4014 (2015
33. Ivanov, I.I., et al. Specific microbiota direct the differentiation of IL-17- producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008
34. Sanos, S.L., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009
35. Cho,M.L., et al. STAT3 and NF-kappaB signal pathway is required for IL-23- mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652-5661 (2006
36. Maher, B.M., et al. Nlrp-3-driven interleukin 17 production by gammadeltaT cells controls infection outcomes during Staphylococcus aureus surgical site infection. Infect. Immun. 81, 4478-4489 (2013
37. O'Brien, L.M., Walsh, E.J., Massey, R.C., Peacock, S.J., & Foster, T.J. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell. Microbiol. 4, 759-770 (2002
38. Zhang, Z., Clarke, T.B., & Weiser, J.N. Cellular effectors mediating Th17- dependent clearance of pneumococcal colonization inmice. J. Clin. Invest. 119, 1899-1909 (2009
39. Nograles, K.E., et al. IL-22-producing "T22" Tcells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123, 1244-1252.e2 (2009
40. Ishigame, H., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119 (2009
41. Midorikawa, K., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71, 3730-3739 (2003
42. Cash, H.L., Whitham, C.V., Behrendt, C.L., & Hooper, L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130 (2006
43. Sestito, R., et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 25, 916-927 (2011
44. Choi, S.M., et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3gamma is required for host defense against MRSA pneumonia. J. Exp. Med. 210, 551-561 (2013
45. Son, E.D., et al. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion. J. Dermatol. Sci. 74, 64-71 (2014
46. Nograles, K.E., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102 (2008
47. Wolk, K., et al. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J. Immunol. 186, 1228-1239 (2011
48. Kreymborg, K., et al. IL-22 is expressed by Th17 cells in an IL-23- dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007
49. Kryczek, I., et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 40, 772-784 (2014
50. Asanuma, H., et al. Isolation and characterization of mouse nasal-Associated lymphoid tissue. J. Immunol. Methods 202, 123-131 (1997